Skip to main content
DIRECT HEALTHCARE PROFESSIONAL COMMUNICATION - Tibsovo▼ 250 mg filmcoated tablets: Interim Supply of Irish packs to Mitigate Supply Disruption
For Healthcare Professionals
Servier Laboratories Limited is currently experiencing supply disruption with TIBSOVOâ–¼ (ivosidenib) in Great Britain.
To ensure continuity in supply, Servier Laboratories Ltd has obtained approval from the MHRA to supply the Tibsovo 250 mg film-coated tablets product in Irish/Maltese Packaging, which is expected to be on the GB market to Q1 2025.
